A61K 9/513
Organic macromolecular compounds
Official title: {Organic macromolecular compounds; Dendrimers}
A61K9/513 (Organic macromolecular compounds) appears on 2,626 US grants and 5,134 published applications in this corpus.
Search patents in A61K- Granted patents
- 2,626
- Published applications
- 5,134
- Assignees
- 1,813
- Inventors
- 9,318
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1977 | 2 | 0 |
| 1978 | 1 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 1 | 0 |
| 1983 | 1 | 0 |
| 1984 | 1 | 0 |
| 1985 | 2 | 0 |
| 1986 | 1 | 0 |
| 1987 | 3 | 0 |
| 1988 | 2 | 0 |
| 1989 | 3 | 0 |
| 1990 | 5 | 0 |
| 1991 | 4 | 0 |
| 1992 | 7 | 0 |
| 1993 | 3 | 0 |
| 1994 | 8 | 0 |
| 1995 | 10 | 0 |
| 1996 | 11 | 0 |
| 1997 | 17 | 0 |
| 1998 | 13 | 0 |
| 1999 | 28 | 0 |
| 2000 | 20 | 0 |
| 2001 | 26 | 11 |
| 2002 | 23 | 45 |
| 2003 | 32 | 65 |
| 2004 | 20 | 63 |
| 2005 | 12 | 67 |
| 2006 | 15 | 104 |
| 2007 | 17 | 93 |
| 2008 | 17 | 103 |
| 2009 | 22 | 113 |
| 2010 | 34 | 160 |
| 2011 | 71 | 172 |
| 2012 | 81 | 156 |
| 2013 | 103 | 192 |
| 2014 | 117 | 267 |
| 2015 | 135 | 241 |
| 2016 | 155 | 294 |
| 2017 | 176 | 298 |
| 2018 | 161 | 258 |
| 2019 | 207 | 296 |
| 2020 | 169 | 318 |
| 2021 | 147 | 324 |
| 2022 | 164 | 308 |
| 2023 | 156 | 340 |
| 2024 | 148 | 304 |
| 2025 | 169 | 285 |
| 2026 | 106 | 257 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Polysaccharide encapsulated oxygen nanobubbles6 Oct 2026US 12,751,927 B2The Board of Trustees of the University of Illinois
- Lipid nanoparticles comprising sterols and mRNA6 Oct 2026US 12,751,999 B2eTheRNA Immunitherapies NV
- Nanosuspension formulation for treatment of pulmonary fibrosis29 Sep 2026US 12,746,210 B2Federal University of Rio De Janeiro
- Particle composition comprising sialic acid binding ligand29 Sep 2026US 12,746,211 B2Cytodigm, Inc.
- Treating vasculature related diseases or disorders using nanoparticles29 Sep 2026US 12,746,212 B2The Regents of the University of California
- Oral targeted nano delivery systems containing geniposide and preparation methods thereof8 Oct 2026US 2026/0306417 A1Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences
- Lipid nanoparticle for delivering nucleic acid drug, and preparation method therefor and use thereof8 Oct 2026US 2026/0306419 A1Cansino (Shanghai) Biological Research Co., Ltd.
- Stable polymer-lipid nanoparticle for drug binding and delivery, especially with anticancer properties, and a method for producing stable polymer-lipid nanoparticles carrying drugs, especially with anticancer properties8 Oct 2026US 2026/0306420 A1Bs Biotechna Spolka Akcyjna
- Preparation of tolerizing nanoparticles for the treatment of primary biliary cholangitis8 Oct 2026US 2026/0306598 A1Cour Pharmaceuticals Development Company, Inc.
- Pulsed electromagnetic field transmission for nanoparticles8 Oct 2026US 2026/0306865 A1New Phase Ltd.
Most cited
By later US patents
- Anti-angiogenic compositions and methods of use968US 5,716,981 AAngiogenesis Technologies, Inc. · 1998
- Biodegradable injectable nanoparticles724US 5,543,158 AMassachusetts Institute of Technology · 1996
- Particle-containing complex porous materials721US 8,268,344 B2The Regents of the University of Michigan · 2012
- Controlled release powder and process for its preparation660US 5,354,556 AElan Corporation, plc · 1994
- Nanoparticles and microparticles of non-linear hydrophilic-hydrophobic multiblock copolymers586US 6,007,845 AMassachusetts Institute of Technology · 1999